GB9827813D0 - Pharmaceutical conjugates - Google Patents

Pharmaceutical conjugates

Info

Publication number
GB9827813D0
GB9827813D0 GBGB9827813.8A GB9827813A GB9827813D0 GB 9827813 D0 GB9827813 D0 GB 9827813D0 GB 9827813 A GB9827813 A GB 9827813A GB 9827813 D0 GB9827813 D0 GB 9827813D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical conjugates
conjugates
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9827813.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Quadrant Holdings Cambridge Ltd
Original Assignee
Andaris Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Andaris Ltd filed Critical Andaris Ltd
Priority to GBGB9827813.8A priority Critical patent/GB9827813D0/en
Publication of GB9827813D0 publication Critical patent/GB9827813D0/en
Priority to PCT/GB1999/003801 priority patent/WO2000035487A1/en
Priority to AU10672/00A priority patent/AU1067200A/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6925—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a microcapsule, nanocapsule, microbubble or nanobubble
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/643—Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]
GBGB9827813.8A 1998-12-17 1998-12-17 Pharmaceutical conjugates Ceased GB9827813D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB9827813.8A GB9827813D0 (en) 1998-12-17 1998-12-17 Pharmaceutical conjugates
PCT/GB1999/003801 WO2000035487A1 (en) 1998-12-17 1999-11-15 Pharmaceutical conjugates comprising two active agents
AU10672/00A AU1067200A (en) 1998-12-17 1999-11-15 Pharmaceutical conjugates comprising two active agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9827813.8A GB9827813D0 (en) 1998-12-17 1998-12-17 Pharmaceutical conjugates

Publications (1)

Publication Number Publication Date
GB9827813D0 true GB9827813D0 (en) 1999-02-10

Family

ID=10844425

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9827813.8A Ceased GB9827813D0 (en) 1998-12-17 1998-12-17 Pharmaceutical conjugates

Country Status (3)

Country Link
AU (1) AU1067200A (en)
GB (1) GB9827813D0 (en)
WO (1) WO2000035487A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0516091D0 (en) * 2005-08-04 2005-09-14 Haemostatix Ltd Therapeutic agent
CN108267577B (en) * 2018-01-15 2020-10-09 广州市妇女儿童医疗中心 EV71 virus IgA antibody detection test strip

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU718956B2 (en) * 1996-10-21 2000-05-04 Quadrant Healthcare (Uk) Limited Platelet substitutes and conjugation methods suitable for their preparation
GB9724143D0 (en) * 1997-11-14 1998-01-14 Andaris Ltd Pharmaceutical conjugate

Also Published As

Publication number Publication date
WO2000035487A1 (en) 2000-06-22
AU1067200A (en) 2000-07-03

Similar Documents

Publication Publication Date Title
HUP0300548A3 (en) Polyol-ifn-betha conjugates
CZ20011518A3 (en) Pharmaceutical preparation
SG79255A1 (en) Pharmaceutical formulations
GB9713980D0 (en) New conjugates
PT1466615E (en) Pharmaceutical composition
HUP0203585A3 (en) Pharmaceutical combinations
PL343769A1 (en) Pharmaceutical composition
EP1145714A4 (en) Drugs
GB9818591D0 (en) Pharmaceutical composition
EG23937A (en) Novel pharmaceutical
PL351135A1 (en) Novel pharmaceutical
HK1044117B (en) Pharmaceutical composition
HRP20010951A2 (en) Pharmaceutical complex
HK1041832A1 (en) Hemoglobin-antioxidant conjugates
EG23946A (en) Novel pharmaceutical
GB9827813D0 (en) Pharmaceutical conjugates
IL126732A0 (en) Pro drug
HU9800078D0 (en) Pharmaceutical composition
GB9923933D0 (en) Novel pharmaceutical
GB9828707D0 (en) Pharmaceutical uses
GB9923934D0 (en) Novel pharmaceutical
GB9818451D0 (en) Conjugates
GB9912039D0 (en) Gene-activating conjugates
GB9926434D0 (en) Pharmaceutical
GB9926437D0 (en) Pharmaceutical

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)